0503.HK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (28 Nov 2023 @ 16:08):

Stats
今日成交量	13.96M
平均成交量	476 561
市值	750.60M
EPS	HKD0 ( 2023-08-24 )
Last Dividend	HKD1.497 ( 2021-09-13 )
Next Dividend	HKD0 ( N/A )
P/E	13.77
ATR14	HKD0.0150 (0.84%)

音量相关性

長: 0.09 (neutral)

短: 0.00 (neutral)

Signal:(54.908) Neutral

Lansen Pharmaceutical 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Lansen Pharmaceutical 相关性 - 货币/商品

-0.27
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.05
( neutral )

-0.58
( weak negative )

0.18
( neutral )

Lansen Pharmaceutical 财务报表

Annual	2022
营收:	HKD65.56M
毛利润:	HKD44.30M (67.57 %)
EPS:	HKD0.0205

FY	2022
营收:	HKD65.56M
毛利润:	HKD44.30M (67.57 %)
EPS:	HKD0.0205

FY	2021
营收:	HKD54.18M
毛利润:	HKD34.41M (63.51 %)
EPS:	HKD0.00224

FY	2020
营收:	HKD54.39M
毛利润:	HKD35.18M (64.68 %)
EPS:	HKD0.218

Financial Reports:

No articles found.

Lansen Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Lansen Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.21 - good (82.09%) | Divividend Growth Potential Score: 2.16 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0136	2011-04-20
Last Dividend	HKD1.497	2021-09-13
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	HKD2.55	--
Avg. Dividend % Per Year	0.00%	--
Score	2.25	--
Div. Sustainability Score	8.21
Div.Growth Potential Score	2.16
Div. Directional Score	5.19	--

Next Divdend (Est)
(2024-07-15)

HKD0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

2.25

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9909.HK	Ex Dividend Knight	2023-11-24	Semi-Annually	0.00%
2161.HK	Ex Dividend Junior	2023-08-15	Annually	0.00%
1161.HK	Ex Dividend Knight	2023-06-12	Annually	0.00%
0239.HK	Ex Dividend Knight	2023-09-29	Semi-Annually	0.00%
3866.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
1731.HK	Ex Dividend Junior	2023-06-23	Sporadic	0.00%
0771.HK	Ex Dividend Junior	2023-05-31	Sporadic	0.00%
2327.HK	Ex Dividend Junior	2023-08-03	Sporadic	0.00%
1290.HK	Ex Dividend Junior	2023-06-14	Sporadic	0.00%
0363.HK	Ex Dividend Knight	2023-06-01	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.114	1.500	7.72	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0424	1.200	8.59	10.00	[0 - 0.3]
returnOnEquityTTM	0.0604	1.500	-0.440	-0.661	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.54	0.800	2.28	1.820	[1 - 3]
quickRatioTTM	1.500	0.800	5.88	4.71	[0.8 - 2.5]
cashRatioTTM	0.939	1.500	5.89	8.84	[0.2 - 2]
debtRatioTTM	0.101	-1.500	8.31	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.00596	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00460	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.144	-1.500	9.43	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.660	1.000	2.33	2.33	[0.2 - 0.8]
operatingProfitMarginTTM	0.191	1.000	8.18	8.18	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.142	1.000	-0.323	-0.323	[0.2 - 2]
assetTurnoverTTM	0.371	0.800	-0.859	-0.687	[0.5 - 2]
Total Score				8.21

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.03	1.000	8.78	0	[1 - 100]
returnOnEquityTTM	0.0604	2.50	-0.283	-0.661	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00460	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00596	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00938	1.500	-3.27	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0388	1.000	-1.530	0	[0.1 - 0.5]
Total Score				2.16

Lansen Pharmaceutical

Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.